In vivo Imaging of Brain Dopaminergic Neurotransmission System in Small Animals with High-resolution Single Photon Emission Computed Tomography.
-
- SAJI Hideo
- Graduate School of Pharmaceutical Sciences, Kyoto University
-
- IIDA Yasuhiko
- Fujimoto Pharmaceutical Corporation
-
- KAWASHIMA Hidekazu
- Graduate School of Pharmaceutical Sciences, Kyoto University
-
- OGAWA Mikako
- Graduate School of Pharmaceutical Sciences, Kyoto University
-
- KITAMURA Youji
- Graduate School of Pharmaceutical Sciences, Kyoto University
-
- MUKAI Takahiro
- Graduate School of Pharmaceutical Sciences, Kyoto University
-
- SHIMAZU Seiichiro
- Fujimoto Pharmaceutical Corporation
-
- YONEDA Fumiro
- Fujimoto Pharmaceutical Corporation
この論文をさがす
抄録
High-resolution single photon emission computed tomography (SPECT) provides a unique capability to image the biodistribution of radiolabeled molecules in small laboratory animals. Thus, we applied the high-resolution SPECT to in vivo imaging of the brain dopaminergic neurotransmission system in common marmosets using two radiolabeled ligands, [123I]2β-carbomethoxy-3β-(4-iodophenyl)tropane (β-CIT) as a dopamine transporter (DAT) ligand and [123I]iodobenzamide (IBZM) as a dopamine D2 receptor (D2R) ligand. Specific images of the striatum, a region with a high density of dopaminergic synapses, were obtained at 240 min and 60 min after injection of [123I]β-CIT and [123I]IBZM, respectively. Furthermore, a significantly low accumulation of [123I]β-CIT in the striatum was observed in MPTP-treated animals compared with results for a control group, and a similar accumulation in the control group was observed with the pretreatment of deprenyl in the MPTP-treated animals. However, the striatal accumulation of [123I]IBZM showed no changes among the control, MPTP-treated, and deprenyl-MPTP-treated groups. These SPECT imaging results agreed well with those of DA concentration and motor behavior. Since MPTP destroys nigrostriatal dopamine nerves and produces irreversible neurodegeneration associated with Parkinsonian syndrome, SPECT imaging data in this study demonstrated that deprenyl shows its neuroprotective effect on Parkinsonism by protecting against the destruction of presynaptic dopamine neurons.
収録刊行物
-
- Analytical Sciences
-
Analytical Sciences 19 (1), 67-71, 2003
社団法人 日本分析化学会
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1390001204258023040
-
- NII論文ID
- 10011102842
- 30013458805
-
- NII書誌ID
- AA10500785
-
- ISSN
- 13482246
- 09106340
-
- NDL書誌ID
- 6408884
-
- PubMed
- 12558026
-
- Web Site
- https://ndlsearch.ndl.go.jp/books/R000000004-I6408884
- https://link.springer.com/content/pdf/10.2116/analsci.19.67.pdf
- https://link.springer.com/article/10.2116/analsci.19.67/fulltext.html
- http://www.jstage.jst.go.jp/article/analsci/19/1/19_1_67/_pdf
- https://search.jamas.or.jp/link/ui/2003149727
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可